![Eduard Enrico Holdener](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eduard Enrico Holdener
Président chez
NOVIMMUNE SA
Profil
Eduard Enrico Holdener is currently the Chairman at NovImmune SA, Director at Cellerix SA, and Director at Swiss Cancer Foundation.
Previously, he served as an Independent Director at PAREXEL International Corp.
from 2015 to 2017, Independent Director at TiGenix NV, Director at HBM Healthcare Investments AG from 2008 to 2021, Non-Executive Director at Ipsen Bioinnovation Ltd., Head of Drug Development at Roche Holding AG from 1995 to 2007, and Chief Medical Officer at F.
Hoffmann-La Roche Ltd. in 2008.
Holdener holds a doctorate degree from the University of Basel and the University of Zurich.
Postes actifs de Eduard Enrico Holdener
| Sociétés | Poste | Début |
|---|---|---|
| NOVIMMUNE SA | Président | 01/02/2008 |
Cellerix SA
 Cellerix SA Pharmaceuticals: GenericHealth Technology Develops and manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/01/2009 |
Swiss Cancer Foundation | Directeur/Membre du Conseil | - |
Anciens postes connus de Eduard Enrico Holdener
| Sociétés | Poste | Fin |
|---|---|---|
| HBM HEALTHCARE INVESTMENTS AG | Directeur/Membre du Conseil | 18/06/2021 |
| PAREXEL INTERNATIONAL CORPORATION | Directeur/Membre du Conseil | 29/09/2017 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/02/2008 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/2007 |
| TIGENIX NV | Directeur/Membre du Conseil | - |
Formation de Eduard Enrico Holdener
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
TiGenix NV
 TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
HBM Healthcare Investments AG
 HBM Healthcare Investments AG Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Novimmune SA
 Novimmune SA BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
Swiss Cancer Foundation | |
Ipsen Bioinnovation Ltd.
 Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
